Safeguarding continuing cardiovascular research excellence and quality publications in France: A working document from the French Society of Cardiology.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 07 11 2018
accepted: 08 11 2018
pubmed: 15 1 2019
medline: 14 6 2019
entrez: 15 1 2019
Statut: ppublish

Résumé

France has a long history of successful cardiovascular research and scientific innovations, but its continued success cannot be taken for granted. To identify current obstacles to cardiovascular research in France and to crystallize the analysis into recommendations for maintained and enhanced research excellence in the future. The French Society of Cardiology set up seven Working Groups, each comprising four to eight cardiologists, covering a spectrum of research institutes, hospitals, specialties, ages and research experience. The Working Groups met regularly in person or by conference call to analyse experiences, refine situation assessments and formulate recommendations for improvements. Results and suggestions were presented to a Core Team, which worked to synthesize, prioritize and organize the findings into a consolidated situation assessment and generate a set of action-orientated recommendations. Four key areas of action were identified: stronger focus on the generation of high-quality data; facilitation of future cardiovascular research; greater promotion and support for research among young cardiologists; and increased focus and support for communications. Most recommendations targeted structural shortcomings and may be implemented at low additional financial cost. It is possible to maintain, and even increase, the quality of cardiovascular research in France and to boost the conversion of successful projects into high-impact publications, without major increases in funding. Intense collaboration between specialties and organizations is necessary to achieve sustainable results.

Sections du résumé

BACKGROUND BACKGROUND
France has a long history of successful cardiovascular research and scientific innovations, but its continued success cannot be taken for granted.
AIMS OBJECTIVE
To identify current obstacles to cardiovascular research in France and to crystallize the analysis into recommendations for maintained and enhanced research excellence in the future.
METHODS METHODS
The French Society of Cardiology set up seven Working Groups, each comprising four to eight cardiologists, covering a spectrum of research institutes, hospitals, specialties, ages and research experience. The Working Groups met regularly in person or by conference call to analyse experiences, refine situation assessments and formulate recommendations for improvements. Results and suggestions were presented to a Core Team, which worked to synthesize, prioritize and organize the findings into a consolidated situation assessment and generate a set of action-orientated recommendations.
RESULTS RESULTS
Four key areas of action were identified: stronger focus on the generation of high-quality data; facilitation of future cardiovascular research; greater promotion and support for research among young cardiologists; and increased focus and support for communications. Most recommendations targeted structural shortcomings and may be implemented at low additional financial cost.
CONCLUSIONS CONCLUSIONS
It is possible to maintain, and even increase, the quality of cardiovascular research in France and to boost the conversion of successful projects into high-impact publications, without major increases in funding. Intense collaboration between specialties and organizations is necessary to achieve sustainable results.

Identifiants

pubmed: 30639198
pii: S1875-2136(18)30193-1
doi: 10.1016/j.acvd.2018.11.002
pii:
doi:

Types de publication

Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-240

Informations de copyright

Copyright © 2018. Published by Elsevier Masson SAS.

Auteurs

Benjamin Alos (B)

Department of Cardiology, CHU La Milétrie, 86021 Poitiers, France.

Mariama Akodad (M)

Department of Cardiology, CHU Arnaud de Villeneuve, 34090 Montpellier, France.

Guillaume Avinee (G)

Department of Cardiology, CHU Rouen, 35033 Rennes, France.

Claire Bouleti (C)

Department of Cardiology, CHU Bichat-Claude-Bernard, 75877 Paris, France.

Pascale Chemaly (P)

Department of Cardiology, centre hospitalier André-Mignot, 78150 Le Chesnay, France.

Cyrielle Desnos (C)

Department of Cardiology, CHU Pitié-Salpêtrière, 75013 Paris, France.

Romain Didier (R)

Department of Cardiology, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France.

Rodrigue Garcia (R)

Department of Cardiology, CHU La Milétrie, 86021 Poitiers, France.

Marianna Mirabel (M)

Department of Cardiology, hôpital européen Georges-Pompidou, 75015 Paris, France.

Delphine Mika (D)

Inserm UMR-S 1180, université Paris-Sud, 92296 Chatenay-Malabry, France.

Benoît Lattuca (B)

Department of Cardiology, CHU Carémeau, 30029 Nîmes, France.

Florent Le Ven (F)

Department of Cardiology, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France.

Vincent Probst (V)

Department of Cardiology, CHU hôtel-Dieu, 44093 Nantes, France.

Martine Gilard (M)

Department of Cardiology, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France. Electronic address: martine.gilard@chu-brest.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH